NCT04686838

Brief Summary

The purpose of the READyR II Study is to test a dynamic tailoring phase of a remote assessment for changing dementia-related care needs.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jul 2021

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 16, 2020

Completed
13 days until next milestone

First Posted

Study publicly available on registry

December 29, 2020

Completed
6 months until next milestone

Study Start

First participant enrolled

July 1, 2021

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 17, 2022

Completed
8 days until next milestone

Study Completion

Last participant's last visit for all outcomes

November 25, 2022

Completed
Last Updated

January 18, 2023

Status Verified

January 1, 2023

Enrollment Period

1.4 years

First QC Date

December 16, 2020

Last Update Submit

January 15, 2023

Conditions

Keywords

Needs AssessmentRemote MonitoringTechnologyCare ValuesAging-in-PlaceFamily Caregiver

Outcome Measures

Primary Outcomes (3)

  • Mean difference effect sizes for pre-post change the care dyad's preparation for future care needs

    The Preparation for Future Care Needs Scale (Short Form) assesses the degree to which an individual has engaged in planning for future care needs in late life using 15 items and 5 subscales representing distinct planning processes (awareness, gathering information, decision making, concrete planning, avoidance). Items are scored on a 5 point Likert scale with higher scores indicating greater preparation for future care needs. Sorensen, S., Chapman, B. P., Duberstein, P. R., Pinquart, M., \& Lyness, J. M. (2017). Assessing future care preparation in late life: Two short measures. Psychol Assess, 29(12), 1480-1495.

    Baseline compared with 18 weeks

  • Mean difference effect sizes for pre-post change in the care dyad's relationship quality

    The Dyadic Relationship Scale assesses the positive dyadic interactions and negative dyadic strain experienced by caregivers (11 items) and care recipients (10 items). Items are averaged for a summary score that ranges from 0 to 3, with higher scores indicating more positive interactions in the relationship, or more relationship strain, respectively. Sebern, M.D. \& Whitlatch, C.J. (2007). Dyadic Relationship Scale: A measure of the impact of the provision and receipt of family care. The Gerontologist, 47(6), 741-751.

    Baseline compared with 18 weeks

  • Mean difference effect sizes for pre-post change in the amount of incongruence between the care partner's understanding of the care values of the person with dementia

    The Care Values Scale assesses the importance of four care-related values to the person with dementia from the perspectives of the person with dementia and their care partner. Items for each of the four subscales are averaged for a summary score that ranges from 1 to 3, with higher scores indicating greater importance of the care value to the person with dementia. Miller LM, Whitlatch CJ, Lee CS, Caserta MS. Care Values in Dementia: Patterns of Perception and Incongruence Among Family Care Dyads. The Gerontologist. 2018.

    Baseline compared with 18 weeks

Secondary Outcomes (3)

  • Mean difference effect sizes for pre-post change in the amount of care-related strain reported

    Baseline compared with 12 weeks

  • Mean difference effect sizes for pre-post change in the care dyad's quality of life

    Baseline compared with 18 weeks

  • Mean difference effect sizes for pre-post change in the care dyad's concealment of emotions

    Baseline compared with 18 weeks

Other Outcomes (4)

  • Time spent out of the home

    Continuously over 18 weeks

  • Physical activity / sedentary behavior

    Continuously over 18 weeks

  • Time spent together / separate

    Continuously over 18 weeks

  • +1 more other outcomes

Study Arms (2)

READyR II A

EXPERIMENTAL

Continuous monitoring will be conducted and analyzed for anomaly detection. Participants in this arm will receive contact phone call when a potential change in care needs is indicated by an anomaly.

Behavioral: READyR II: A

READyR II B (comparison)

ACTIVE COMPARATOR

Sensors will remain in the home but anomaly detection analysis will not be performed and contact phone calls will be at regular intervals without dynamic tailoring content. Standard educational content will instead be shared over the phone.

Behavioral: READyR II: B

Interventions

READyR II: ABEHAVIORAL

Continuous monitoring for anomaly detection and contact phone call when a potential change in care needs is indicated by an anomaly.

READyR II A
READyR II: BBEHAVIORAL

Sensors will remain in the home but anomaly detection analysis will not be performed and contact phone calls will be at regular intervals without dynamic tailoring content.

READyR II B (comparison)

Eligibility Criteria

Age21 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • years or older;
  • Able to identify a family care partner over age 20 who is living with you and will also consent to fully participate in the study
  • Probable or confirmed diagnosis of mild cognitive impairment or early-stage dementia
  • Age and education adjusted MOCA score \> 15 (at most recent measurement by parent study) corresponding to early to moderate stage dementia

You may not qualify if:

  • Inability to speak English or read printed materials in English
  • Conditions that would limit participation at entry to study (e.g. visual or hearing impairments prohibiting reading and discussing the intervention materials)
  • Any uncontrolled medical condition that is expected to preclude completion of the study, such as late stage cancers
  • Family Care Partners
  • years or older;
  • Self-identifying as a family member and care partner residing with the PwD participant;
  • Inability to speak English or read printed materials in English
  • Conditions that would limit participation at entry to study (e.g. visual or hearing impairments prohibiting reading and discussing the intervention materials);
  • Any uncontrolled medical condition that is expected to preclude completion of the study, such as late stage cancers.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Oregon Health & Science University

Portland, Oregon, 97239, United States

Location

MeSH Terms

Conditions

DementiaAlzheimer Disease

Condition Hierarchy (Ancestors)

Brain DiseasesCentral Nervous System DiseasesNervous System DiseasesNeurocognitive DisordersMental DisordersTauopathiesNeurodegenerative Diseases

Study Officials

  • Lyndsey M Miller, PhD

    Oregon Health and Science University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Masking Details
Participants will all agree to the dynamic tailoring phase with remote monitoring and surveys, and will not know whether the phone calls are related to anomaly detection or are a control condition phone call.
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Model Details: Dyads will be randomized (assigned by chance) to one of two groups: 1) READyR A or 2) READyR B
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Co-Principal Investigator

Study Record Dates

First Submitted

December 16, 2020

First Posted

December 29, 2020

Study Start

July 1, 2021

Primary Completion

November 17, 2022

Study Completion

November 25, 2022

Last Updated

January 18, 2023

Record last verified: 2023-01

Data Sharing

IPD Sharing
Will share

De-identified IPD will be available upon request to our Alzheimer's Disease Research Center Supporting Information: Time Frame: Data will become available after completion of study and after publication of primary study aims. Access Criteria: Requests need to made to the PI at the Oregon Alzheimer's Disease Research Center (OARDC). A short data request form will need to be submitted to the OADRC.

Shared Documents
STUDY PROTOCOL, SAP, ICF, ANALYTIC CODE

Locations